Completed

Cosmetic Product for Improving Skin Moisturization and Barrier in Adults with Dry, Sensitive Skin

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate the effectiveness of a cosmetic product in improving skin moisturization and barrier function in adults with dry, sensitive skin over a period of 28 days.

What is being tested

Repairing cream

Other
Who is being recruted

From 18 to 65 Years
+25 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: December 2024
See protocol details

Summary

Principal SponsorLacer S.A.
Last updated: February 7, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 17, 2024

Actual date on which the first participant was enrolled.

This clinical trial aims to find out if a specific cosmetic product can improve skin condition in adults who have dry, very dry, sensitive, and cracked skin that shows discomfort. The trial seeks to answer two main questions: whether the cosmetic product can increase skin hydration and skin barrier function, and if it can improve signs of skin discomfort. The potential outcomes of this study could help in managing dry and sensitive skin conditions more effectively. Participants in this trial will use the cosmetic product twice a day for a period of one month. They will also visit the research center on the first, second, seventh, and twenty-eighth day of product use for evaluations. The effectiveness of the product will be measured by changes in skin barrier function and skin moisturization from the start to the end of the trial. Skin barrier function is defined by the amount of water loss through the skin, with a lower value indicating improved skin barrier function. Skin hydration is defined by the skin's capacity to hold water, with a higher value indicating more hydrated skin.

Official TitleClinical Instrumental Evaluation of the Efficacy of a Cosmetic Product in Improving Skin Moisturization and Skin Barrier
Principal SponsorLacer S.A.
Last updated: February 7, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

35 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

12 inclusion criteria required to participate
Subject informed about the study procedures and having signed the privacy policy

Healthy female and male subjects (without specific repartition)

Caucasian ethnicity

Aged between 18 and 65 years old

Show More Criteria

13 exclusion criteria prevent from participating
Subjects deprived of freedom by administrative or legal decision or under guardianship

Subjects that have shown allergies or sensitivity to cosmetic products, drugs, patch or medical devices

Subjects with acute or chronic diseases able to interfere with the outcome of the study or that are considered dangerous for the subject or incompatible with the study requirements

Subjects participating or planning to participate in other clinical trials

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Subjects applied tested product on right or left leg (as per randomization) and the other leg was left untreated and acted as control area. The product was applied twice a day during 1 month.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Complife Italia

San Martino Siccomario, ItalyOpen Complife Italia in Google Maps
CompletedOne Study Center